New eye drops aim to soothe dry eyes in clinical trial
NCT ID NCT07369375
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether VMX eye drops can improve tear film stability and reduce dry eye symptoms compared to standard care. About 76 adults with mild to moderate dry eye disease will receive either VMX drops or a control. The main goal is to see if the drops help eyes stay moist longer and ease discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New eye drop aims to soothe dryness after cataract surgery
- Can simple eye drops soothe dry eyes? new study puts OTC brands to the test
- New eye drop hopes to soothe dry eye sufferers
- New eye drops aim to calm Sjögren's dry eye by blocking inflammation
- Can a simple eye drop stop dry eye after LASIK?
- Dry eye sufferers: are preservatives in your eye drops making things worse?